SWA
DNA icon

Stratos Wealth Advisors’s Ginkgo Bioworks DNA Stock Holding History

Stratos Wealth Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-255
Closed -$19K – 679
2023
Q2 		$19K Buy
+255
New +$15.1K ﹤0.01% 622

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Stratos Wealth Advisors's DNA Position: Q3 2023 in Review

Stratos Wealth Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2023, closing a stake of 255 shares — an estimated $19K sold.

Stratos Wealth Advisors first reported a position in DNA in Q2 2023 and held it in 1 quarter. The position peaked at $19K in Q2 2023. 348 funds tracked by Wall St. Rank hold DNA as of Q3 2023.

  • Stratos Wealth Advisors reported no remaining Ginkgo Bioworks position as of Q3 2023 after selling out during the quarter.
  • Stratos Wealth Advisors sold 255 Ginkgo Bioworks shares in Q3 2023, an estimated $19K.
  • Stratos Wealth Advisors first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 1 quarter.
  • Stratos Wealth Advisors's Ginkgo Bioworks position peaked at $19K in Q2 2023.
  • 348 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2023.

Based on Stratos Wealth Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.